<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417338</url>
  </required_header>
  <id_info>
    <org_study_id>CIFuwaiHospital</org_study_id>
    <nct_id>NCT01417338</nct_id>
  </id_info>
  <brief_title>Registry for Pulmonary Hypertension in China</brief_title>
  <official_title>National, Prospective, Multicenter,Observational Registry Study on Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To characterize the demographics and clinical course of the patient population diagnosed
           as having WHO group I pulmonary arterial hypertension and WHO group IV pulmonary
           hypertension due to chronic thromboembolic pulmonary hypertension

        2. To describe real-world outcome of Chinese patients with WHO group I pulmonary arterial
           hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic
           pulmonary hypertension

        3. To evaluate differences in patient outcomes according to classification subgroup

        4. To identify clinical predictors of long-term survival

        5. To assess the relationship between targeted therapies for pulmonary arterial
           hypertension and patient outcomes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data describing the natural history of idiopathic and familial pulmonary arterial
      hypertension were derived from a registry conducted at our institution prior to 2006. Since
      then, targeted therapies for pulmonary arterial hypertension have been introduced in China.
      It is probably that the prognosis of Chinese patients with WHO group I pulmonary arterial
      hypertension and WHO group IV pulmonary hypertension due to chronic thromboembolic pulmonary
      hypertension has also been improved as western countries. Therefore, the aim of the present
      study was to describe real-world outcome of Chinese patients with pulmonary arterial
      hypertension and chronic thromboembolic pulmonary hypertension and identify factors that may
      predict outcome. Our study will provide an updated picture of the clinical course of a more
      broadly defined scope of pulmonary hypertension and the effects of current therapy on
      survival, enabling the collection of data on demographics, clinical course, treatments, and
      outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>5 years</time_frame>
    <description>The time from diagnosis to the date of occurrence of death, or need to perform atrial Septostomy and lung transplantation, or to the deadline of the study. The average follow-up period is 5 years.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3079</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <condition>Death</condition>
  <arm_group>
    <arm_group_label>Pulmonary hypertension group</arm_group_label>
    <description>Patients who were firstly diagnosed as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients who were firstly diagnosed as pulmonary arterial hypertension or
        chronic thromboembolic pulmonary hypertension at 53 participating institutions in China
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed patients'consent

          -  Diagnosed by right heart catheterization one month within study enrollment

          -  patients who were firstly diagnosed as pulmonary arterial hypertension or chronic
             thromboembolic pulmonary hypertension

        Exclusion Criteria:

          -  Not meeting inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian-Guo He, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fu Wai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jian-Guo He, M.D.</last_name>
    <phone>86-10-88398060</phone>
    <email>hejianguofw@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fu Wai Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jian-Guo He, M.D. &amp; Ph.D</last_name>
      <phone>86-10-88398060</phone>
      <email>hejianguofw@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://reg.fwncpc.com/</url>
    <description>Data transmission system</description>
  </link>
  <reference>
    <citation>Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 Feb;137(2):376-87. doi: 10.1378/chest.09-1140. Epub 2009 Oct 16.</citation>
    <PMID>19837821</PMID>
  </reference>
  <reference>
    <citation>Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010 Jul 13;122(2):164-72. doi: 10.1161/CIRCULATIONAHA.109.898122. Epub 2010 Jun 28.</citation>
    <PMID>20585012</PMID>
  </reference>
  <reference>
    <citation>D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991 Sep 1;115(5):343-9.</citation>
    <PMID>1863023</PMID>
  </reference>
  <reference>
    <citation>Duffels MG, Engelfriet PM, Berger RM, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007 Aug 21;120(2):198-204. Epub 2006 Dec 19.</citation>
    <PMID>17182132</PMID>
  </reference>
  <reference>
    <citation>Fasnacht MS, Tolsa JF, Beghetti M; Swiss Society for Pulmonary Arterial Hypertension. The Swiss registry for pulmonary arterial hypertension: the paediatric experience. Swiss Med Wkly. 2007 Sep 8;137(35-36):510-3.</citation>
    <PMID>17990138</PMID>
  </reference>
  <reference>
    <citation>Fischler M, Speich R, Dorschner L, Nicod L, Domenighetti G, Tamm M, Rochat T, Aubert JD, Ulrich S; Swiss Society for Pulmonary Hypertension. Pulmonary hypertension in Switzerland: treatment and clinical course. Swiss Med Wkly. 2008 Jun 28;138(25-26):371-8. doi: 2008/25/smw-11914.</citation>
    <PMID>18587689</PMID>
  </reference>
  <reference>
    <citation>Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30. Epub 2006 Feb 2.</citation>
    <PMID>16456139</PMID>
  </reference>
  <reference>
    <citation>Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, Wang ZW, Cheng XS, Xu B, Hu SS, Hui RT, Yang YJ. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007 Aug;132(2):373-9. Epub 2007 Mar 30.</citation>
    <PMID>17400671</PMID>
  </reference>
  <reference>
    <citation>McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, Miller DP, Feldkircher K, Giles S. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008 Aug;83(8):923-31. doi: 10.4065/83.8.923.</citation>
    <PMID>18674477</PMID>
  </reference>
  <reference>
    <citation>Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003 Nov;62(11):1088-93.</citation>
    <PMID>14583573</PMID>
  </reference>
  <reference>
    <citation>Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug;107(2):216-23.</citation>
    <PMID>3605900</PMID>
  </reference>
  <reference>
    <citation>Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest. 2000 Mar;117(3):870-4.</citation>
    <PMID>10713017</PMID>
  </reference>
  <reference>
    <citation>Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007 Dec;30(6):1103-10. Epub 2007 Sep 5.</citation>
    <PMID>17804449</PMID>
  </reference>
  <reference>
    <citation>Tueller C, Stricker H, Soccal P, Tamm M, Aubert JD, Maggiorini M, Zwahlen M, Nicod L; Swiss Society for Pulmonary Hypertension. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84. doi: 2008/25/smw-11915.</citation>
    <PMID>18587690</PMID>
  </reference>
  <reference>
    <citation>Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010 Jul 13;122(2):156-63. doi: 10.1161/CIRCULATIONAHA.109.911818. Epub 2010 Jun 28.</citation>
    <PMID>20585011</PMID>
  </reference>
  <reference>
    <citation>Zhang R, Dai LZ, Xie WP, Yu ZX, Wu BX, Pan L, Yuan P, Jiang X, He J, Humbert M, Jing ZC. Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era. Chest. 2011 Aug;140(2):301-309. doi: 10.1378/chest.10-2327. Epub 2011 Feb 17.</citation>
    <PMID>21330386</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>August 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <last_update_submitted>June 7, 2017</last_update_submitted>
  <last_update_submitted_qc>June 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Jianguo He</investigator_full_name>
    <investigator_title>Director of Pulmonary vascular disease center</investigator_title>
  </responsible_party>
  <keyword>Hypertension,pulmonary</keyword>
  <keyword>Mortality</keyword>
  <keyword>Risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

